Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | WEE1 | P30291 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10011887 | 0.84 | HSP90AA1 (0.50) | HSP90AA1ANPEPDPP4MAPK1ALOX5 | |
| SCHEMBL7767567 | 0.83 | TRPA1 (0.42) | HSP90AA1ANPEPDPP4MAPK1MAPT | |
| SCHEMBL18913903 | 0.81 | SMN1; SMN2 (0.57) | MAPK1ALOX5MAPTLMNAHTT | |
| SCHEMBL10672625 | 0.79 | ANPEP (0.50) | HSP90AA1ANPEPDPP4MAPK1ALOX5 | |
| SCHEMBL15147226 | 0.79 | KMT2A (0.41) | HSP90AA1MAPTLMNAALDH1A1TDP1 | |
| SCHEMBL29625130 | 0.78 | NPC1 (0.52) | HSP90AA1ALOX5MAPTHTTALDH1A1 | |
| SCHEMBL547889 | 0.78 | NPC1 (0.52) | HSP90AA1ALOX5MAPTHTTALDH1A1 | |
| SCHEMBL1245326 | 0.78 | HSD17B10 (0.50) | HSP90AA1MAPK1ALOX5MAPTLMNA | |
| Phenol SCHEMBL7138886 | 0.77 | ALOX5 (0.57) | HSP90AA1MAPK1ALOX5MAPTTDP1 | |
| Water SCHEMBL8683475 | 0.76 | NPC1 (0.50) | HSP90AA1ALOX5MAPTHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2835368-B1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECH CORP (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2835368-A1 | Process for Isolation of Monophenolic-Bisaryl Triazines | CYTEC TECHNOLOGY CORP. (US) | 2015-02-11 | — | — | EP | disclosed |
| EP-1397352-B1 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | CYTEC TECH CORP (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2289884-A1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECHNOLOGY CORP. (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2280005-A1 | Process for isolation of monophenolic bisaryl triazines | CYTEC TECHNOLOGY CORP. (US) | 2011-02-02 | — | — | EP | disclosed |
| US-20040073028-A1 | Process for isolation of monophenolic-bisaryl triazines | GUPTA RAM BABOO (US) | 2004-04-15 | — | — | US | disclosed |
| EP-1397352-A2 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | Cytec Technology Corp. (US) | 2004-03-17 | — | — | EP | disclosed |
| US-6632944-B2 | Such as 2-(2,4-dihydroxyphenyl)-4,6-bis(2,3-dimethylphenyl)-1,3,5-triazine via solvent extraction; for ultraviolet radiation absorption | CYTEC TECHNOLOGY CORP. | 2003-10-14 | — | — | US | disclosed |
| US-20030013879-A1 | Process for isolation of monophenolic-bisaryl triazines | CYTEC TECHNOLOGY CORP. | 2003-01-16 | — | — | US | disclosed |
| WO-2003000667-A2 | PROCESS FOR ISOLATION OF MONOPHENOLIC-BISARYL TRIAZINES | CYTEC TECHNOLOGY CORP. (US) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073028-A1 | Process for isolation of monophenolic-bisaryl triazines | ADH1C, TET2, AHR | HSP90AA1 3414/4885ANPEP 2941/4885DPP4 2377/4885 |
| US-20030013879-A1 | Process for isolation of monophenolic-bisaryl triazines | ADH1C, TET2, AHR | HSP90AA1 3414/4885ANPEP 2941/4885DPP4 2377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.